Letters
Long term statin treatment
Exaggerated report of benefits in a flawed long term statin treatment study
BMJ 2017; 359 doi: https://doi.org/10.1136/bmj.j4915 (Published 31 October 2017) Cite this as: BMJ 2017;359:j4915- David Diamond, professor1,
- Malcolm Kendrick, general practitioner2,
- Luca Mascitelli, army medical corps officer and cardiologist3
- 1Departments of Psychology, Molecular Pharmacology and Physiology, University of South Florida, Tampa, Florida 33647, USA
- 2East Cheshire Trust, Macclesfield District General Hospital, Macclesfield, UK
- 3Medical Service, Comando Brigata Alpina “Julia”/Multinational Land Force, Udine, Italy
- ddiamond{at}usf.edu
The BMJ reports on the findings of a study on long term (20 year) treatment with a statin in the WOSCOPS trial by Vallejo-Vaz et al.12 The news article and publication report that, in this primary prevention trial, pravastatin reduced deaths from heart disease by 28% in men with high levels of LDL cholesterol. But 28% …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.